Back to 
Capital International, Inc./CA/
Capital International, Inc./CA/
SGEN
Showing 0 of 8 quarters
Position history for Capital International, Inc./CA/'s holdings in SEATTLE GENETICS INC
As of its Q3 2020 13F, Capital International held 750,143 shares of SGEN (Seattle Genetics), worth $146.8M. Capital International's 13F filings listed SGEN from Q1 2019 to Q3 2020, 7 quarterly filings. SGEN was 1.6% of Capital International's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.